Risk factors for ICU mortality |
Survived (n=60) |
Deceased (n=16) |
p value |
Age, years |
53,79 ± 18,95 |
59,37 ± 14,36 |
0,26 |
Female sex (%) |
10 (16,67) |
9 (56,25) |
<0,01 |
Patients baseline conditions (%) |
|
|
|
Alcohol abuse (%) |
3 (5) |
2 (12,5) |
0,32 |
Cirrhosis (%) |
1 (1,67) |
1 (6,25) |
0,36 |
COPD (%) |
11 (18,33) |
3 (43,7) |
0,91 |
Diabetes (%) |
6 (10) |
3 (43,75) |
0,36 |
Surgery (%) |
30 (50) |
11 (68,75) |
0,22 |
Charlson Comorbidity Index |
1,36 ± 2,04 |
1,94 ± 1,73 |
0,51 |
Previous 6 months hospitalisation (%) |
19 (31,67) |
6 (37,5) |
0,66 |
Provenance from other wards (%) |
26 (43,33) |
11 (68,75) |
0,10 |
Days of pre-ICU hospitalisation |
2,57 ± 8,86 |
5,87 ± 6,56 |
0,15 |
Predicted mortality by SAPS |
|
|
0,24 |
SAPS II |
44,64 ± 15,19 |
51 ± 16,04 |
|
SAPS III |
62.42 ± 20,40 |
60,33 ± 17,27 |
|
Duration of antibiotic therapy, days |
18,46 ± 11,63 |
20,75 ± 23,64 |
0,64 |
Central venous catheter (%) |
57 (95) |
16 (100) |
0,95 |
Number of catheter-days |
20 ± 13,49 |
31,57 ± 26,25 |
0,03 |
Length of mechanical ventilation, days |
17,42 ± 10,79 |
31,25 ± 26,73 |
<0,01 |
Pseudomonas infection (%) |
27( 45) |
11 (68,75) |
0,88 |
Multi Drug Resistant pathogen infection (%) |
13 (21,67) |
5 (31,25) |
0,072 |
MDR-Pseudomonas VAP (%) |
9 (69,23) |
5(100) |
|
Dialysis (%) |
2 (3,33) |
4 (25) |
0,01 |
Duration of dialysis, days |
1,36 ± 6,21 |
2,25 ± 5,98 |
0,12 |
Steroid therapy (%) |
14 (23,33) |
7 (43,75) |
<0,01 |
Days with steroid therapy |
2,08 ± 5,46 |
4,57 ± 9,21 |
0,93 |
Tracheostomy (%) |
54 (90) |
12 (75) |
0,11 |
Days of hospital stay preceding VAP |
7,87 ± 7,61 |
13,06 ± 12,34 |
0,48 |
Length of hospital stay, days |
23,76 ± 13,57 |
28,87 ± 24,83 |
0.10 |
|